NEW YORK (GenomeWeb) – Investment banks Mizuho Securities and William Blair today downgraded Bruker's shares, following the company's announcement that CFO Charles Wagner is resigning effective June 12. 

Mizuho downgraded Bruker to a Neutral rating from a previous Buy rating, while William Blair downgraded the firm to Market Perform from Outperform. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.